[go: up one dir, main page]

AU2003282069A8 - Tumor marker proteins for diagnosis and therapy of cancer and cancer risk assessment - Google Patents

Tumor marker proteins for diagnosis and therapy of cancer and cancer risk assessment

Info

Publication number
AU2003282069A8
AU2003282069A8 AU2003282069A AU2003282069A AU2003282069A8 AU 2003282069 A8 AU2003282069 A8 AU 2003282069A8 AU 2003282069 A AU2003282069 A AU 2003282069A AU 2003282069 A AU2003282069 A AU 2003282069A AU 2003282069 A8 AU2003282069 A8 AU 2003282069A8
Authority
AU
Australia
Prior art keywords
cancer
diagnosis
therapy
risk assessment
tumor marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003282069A
Other versions
AU2003282069A1 (en
Inventor
Silvia Tortola Perez
Thomas Buschmann
Jorn Meuer
Volker Seibert
Kirsten Rothmann-Cosic
Tatiana Ilyina
Marie-Laure Fogeron
Mark Van Der Linden
Steffen Heim
Stephanie Lamer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EUROPROTEOME AG
Original Assignee
EUROPROTEOME AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EUROPROTEOME AG filed Critical EUROPROTEOME AG
Publication of AU2003282069A1 publication Critical patent/AU2003282069A1/en
Publication of AU2003282069A8 publication Critical patent/AU2003282069A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2003282069A 2002-11-01 2003-10-31 Tumor marker proteins for diagnosis and therapy of cancer and cancer risk assessment Abandoned AU2003282069A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02090365 2002-11-01
EP02090365.4 2002-11-01
PCT/EP2003/012162 WO2004040298A2 (en) 2002-11-01 2003-10-31 Tumor marker proteins for diagnosis and therapy of cancer and cancer risk assessment

Publications (2)

Publication Number Publication Date
AU2003282069A1 AU2003282069A1 (en) 2004-05-25
AU2003282069A8 true AU2003282069A8 (en) 2004-05-25

Family

ID=32187248

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003282069A Abandoned AU2003282069A1 (en) 2002-11-01 2003-10-31 Tumor marker proteins for diagnosis and therapy of cancer and cancer risk assessment

Country Status (2)

Country Link
AU (1) AU2003282069A1 (en)
WO (1) WO2004040298A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20050881A1 (en) * 2005-05-16 2006-11-17 Anna Favre DIAGNOSTIC KIT FOR HIRSCHSPRUNG MEGALON CONGENITAL DISEASE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001251013A1 (en) * 2000-03-28 2001-10-08 Diadexus, Inc. Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer
DE10053047A1 (en) * 2000-10-13 2002-06-06 Univ Lausanne Epalinges Use of caveolin polypeptide or caveolin nucleic acid for treating cell proliferation-associated disorder e.g., cancer such as non-steroid dependent carcinoma, stomach carcinoma or colon carcinoma

Also Published As

Publication number Publication date
AU2003282069A1 (en) 2004-05-25
WO2004040298A2 (en) 2004-05-13
WO2004040298A3 (en) 2005-06-09

Similar Documents

Publication Publication Date Title
AU2003302892A8 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2003225573A8 (en) Identification of ovarian cancer tumor markers and therapeutic targets
HUP0200760A2 (en) Compounds and methods for therapy and diagnosis of lung cancer
HUP0201757A2 (en) Compositoins and methods for the therapy and diagnosis of lung cancer
EP1571968A4 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1589933A4 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1578996A4 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1553912A4 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1572091A4 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1575571A4 (en) Compositions and methods for the diagnosis and treatment of tumor
AU2002251366A1 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
AU2003217397A8 (en) Claudins, markers for diagnosis, prognosis and therapy of breast, bone, brain cancer
AU2002364501A1 (en) Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
AU2003246592A1 (en) Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases
AU2003245927A1 (en) Target genes for the diagnosis and treatment of cancer
AU2003250912A8 (en) Agents and methods for diagnosis and therapy of cancer and cancer risk assessment
AU2003230849A8 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2003260301A8 (en) Diagnostic and therapeutic use of ensadin-0581 gene and protein for neurodegenerative diseases
AU2003282069A8 (en) Tumor marker proteins for diagnosis and therapy of cancer and cancer risk assessment
AU2003293130A8 (en) Methods for identifying risk of breast cancer and treatments thereof
AU2002251367A1 (en) Proteins and genes for diagnosis and treatment of erbb2-related cancer
AU2003263036A8 (en) Span-xb gene and protein for the diagnosis and treatment of cancer
AU2003279312A8 (en) Diagnostic and therapeutic use of ensadin-0289 gene and protein for neurodegenerative diseases
AU2003298742A8 (en) Methods for identifying risk of breast cancer and treatments thereof
AU2002332606A8 (en) Compositions and methods for the therapy and diagnosis of colon cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase